Cargando…
Frovatriptan and Rizatriptan Economic EVAluation: the FREEVA study
BACKGROUND: The present pharmacoeconomic study compared the direct and indirect costs of using frovatriptan versus rizatriptan in the acute treatment of migraine. METHODS: Data on the cost-efficacy of the two triptans were derived from a recently published Italian, multicenter, randomized, double-bl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878870/ https://www.ncbi.nlm.nih.gov/pubmed/24330707 http://dx.doi.org/10.1186/1129-2377-14-96 |